CCL5/CCR1 axis regulates multipotency of human adipose tissue derived stromal cells

Stem Cell Research

Volumn 10, Issue 2, 2013, Pages 166-178

  Kauts, Mari Liis ^a   Pihelgas, Susan ^a   Orro, Kadri ^a   Neuman, Toomas ^a,b   Piirsoo, Alla ^a  

^a Protobios LCC   (Estonia)

^b TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN KINASE B; RANTES; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ADIPOSE TISSUE CELL; ADIPOSE TISSUE DERIVED STROMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; DONOR; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTION INITIATION; UPREGULATION;

ADIPOSE TISSUE; CELL SEPARATION; CHEMOKINE CCL3; CHEMOKINE CCL5; GENE EXPRESSION REGULATION; HUMANS; MULTIPOTENT STEM CELLS; NF-KAPPA B; RECEPTORS, CCR1; RNA, MESSENGER; SIGNAL TRANSDUCTION; STROMAL CELLS; TISSUE DONORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84871778827     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2012.11.004     Document Type: Article

References (56)

1. Alessio N., Squillaro T., Cipollaro M., Bagella L., Giordano A., Galderisi U. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways. Oncogene 2010, 29:5452-5463.
2. Amos P.J., Shang H., Bailey A.M., Taylor A., Katz A.J., Peirce S.M. IFATS collection: the role of human adipose-derived stromal cells in inflammatory microvascular remodeling and evidence of a perivascular phenotype. Stem Cells 2008, 26:2682-2690.
3. Baek S.J., Kang S.K., Ra J.C. In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Exp. Mol. Med. 2011, 43:596-603.
4. Bendall L. Chemokines and their receptors in disease. Histol. Histopathol. 2005, 20:907-926.
5. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 2007, 213:341-347.
6. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
7. Chandele A., Prasad V., Jagtap J.C., Shukla R., Shastry P.R. Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis. Neoplasia 2004, 6:29-40.
8. Chu Z.L., McKinsey T.A., Liu L., Gentry J.J., Malim M.H., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:10057-10062.
9. De Ugarte D.A., Morizono K., Elbarbary A., Alfonso Z., Zuk P.A., Zhu M., Dragoo J.L., Ashjian P., Thomas B., Benhaim P., Chen I., Fraser J., Hedrick M.H. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003, 174:101-109.
10. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
11. Drake M.T., Shenoy S.K., Lefkowitz R.J. Trafficking of G protein-coupled receptors. Circ. Res. 2006, 99:570-582.
12. Fox J.M., Chamberlain G., Ashton B.A., Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br. J. Haematol. 2007, 137:491-502.
13. Garrington T.P., Johnson G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 1999, 11:211-218.
14. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 2007, 100:1249-1260.
15. Gimble J.M., Guilak F., Bunnell B.A. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 2010, 1:19.
16. Greco S.J., Liu K., Rameshwar P. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 2007, 25:3143-3154.
17. Hayden M.S., Ghosh S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012, 26:203-234.
18. Honczarenko M., Le Y., Swierkowski M., Ghiran I., Glodek A.M., Silberstein L.E. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006, 24:1030-1041.
19. Izadpanah R., Trygg C., Patel B., Kriedt C., Dufour J., Gimble J.M., Bunnell B.A. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J. Cell. Biochem. 2006, 99:1285-1297.
20. Jang S.W., Kim Y.S., Lee Y.H., Ko J. Role of human LZIP in differential activation of the NF-kappaB pathway that is induced by CCR1-dependent chemokines. J. Cell. Physiol. 2007, 211:630-637.
21. John A., Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 2001, 7:14-23.
22. Kang Y.J., Jeon E.S., Song H.Y., Woo J.S., Jung J.S., Kim Y.K., Kim J.H. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J. Cell. Biochem. 2005, 95:1135-1145.
23. Lamfers M., Idema S., van Milligen F., Schouten T., van der Valk P., Vandertop P., Dirven C., Noske D. Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. Cancer Lett. 2009, 274:78-87.
24. Lee M.J., Jeon E.S., Lee J.S., Cho M., Suh D.S., Chang C.L., Kim J.H. Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells. J. Cell. Biochem. 2008, 104:499-510.
25. Lin T.M., Chang H.W., Wang K.H., Kao A.P., Chang C.C., Wen C.H., Lai C.S., Lin S.D. Isolation and identification of mesenchymal stem cells from human lipoma tissue. Biochem. Biophys. Res. Commun. 2007, 361:883-889.
26. Madonna R., Geng Y.J., De Caterina R. Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1723-1729.
27. Martin L., Blanpain C., Garnier P., Wittamer V., Parmentier M., Vita C. Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry 2001, 40:6303-6318.
28. Meshorer E., Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat. Rev. Mol. Cell Biol. 2006, 7:540-546.
29. Neote K., DiGregorio D., Mak J.Y., Horuk R., Schall T.J. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993, 72:415-425.
30. Ng H.H., Surani M.A. The transcriptional and signalling networks of pluripotency. Nat. Cell Biol. 2011, 13:490-496.
31. Noel D., Caton D., Roche S., Bony C., Lehmann S., Casteilla L., Jorgensen C., Cousin B. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp. Cell Res. 2008, 314:1575-1584.
32. Pan G., Li J., Zhou Y., Zheng H., Pei D. A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J. 2006, 20:1730-1732.
33. Parekkadan B., Milwid J.M. Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 2010, 12:87-117.
34. Park S.B., Seo K.W., So A.Y., Seo M.S., Yu K.R., Kang S.K., Kang K.S. SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC. Cell Death Differ. 2012, 19:534-545.
35. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 2001, 22:153-183.
36. Riekstina U., Cakstina I., Parfejevs V., Hoogduijn M., Jankovskis G., Muiznieks I., Muceniece R., Ancans J. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev. 2009, 5:378-386.
37. Roscic-Mrkic B., Fischer M., Leemann C., Manrique A., Gordon C.J., Moore J.P., Proudfoot A.E., Trkola A. RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood 2003, 102:1169-1177.
38. Ruster B., Gottig S., Ludwig R.J., Bistrian R., Muller S., Seifried E., Gille J., Henschler R. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006, 108:3938-3944.
39. Ryan J.M., Barry F., Murphy J.M., Mahon B.P. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin. Exp. Immunol. 2007, 149:353-363.
40. Saulnier N., Puglisi M.A., Lattanzi W., Castellini L., Pani G., Leone G., Alfieri S., Michetti F., Piscaglia A.C., Gasbarrini A. Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation. Cytotherapy 2011, 13:329-340.
41. Slimani H., Charnaux N., Mbemba E., Saffar L., Vassy R., Vita C., Gattegno L. Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells. Glycobiology 2003, 13:623-634.
42. Sordi V., Malosio M.L., Marchesi F., Mercalli A., Melzi R., Giordano T., Belmonte N., Ferrari G., Leone B.E., Bertuzzi F., Zerbini G., Allavena P., Bonifacio E., Piemonti L. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005, 106:419-427.
43. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
44. Takashima, A., 2001. Establishment of fibroblast cultures. Curr. Protoc. Cell Biol. Chapter 2, Unit 2.1.
45. Tallone T., Realini C., Bohmler A., Kornfeld C., Vassalli G., Moccetti T., Bardelli S., Soldati G. Adult human adipose tissue contains several types of multipotent cells. J. Cardiovasc. Transl. Res. 2011, 4:200-210.
46. Vlahakis S.R., Villasis-Keever A., Gomez T., Vanegas M., Vlahakis N., Paya C.V. G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. J. Immunol. 2002, 169:5546-5554.
47. Von Luttichau I., Notohamiprodjo M., Wechselberger A., Peters C., Henger A., Seliger C., Djafarzadeh R., Huss R., Nelson P.J. Human adult CD34-progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev. 2005, 14:329-336.
48. Wagner W., Wein F., Seckinger A., Frankhauser M., Wirkner U., Krause U., Blake J., Schwager C., Eckstein V., Ansorge W., Ho A.D. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 2005, 33:1402-1416.
49. Weber C., Weber K.S., Klier C., Gu S., Wank R., Horuk R., Nelson P.J. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood 2001, 97:1144-1146.
50. Winter A., Breit S., Parsch D., Benz K., Steck E., Hauner H., Weber R.M., Ewerbeck V., Richter W. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum. 2003, 48:418-429.
51. Wu Y., Yoder A. Chemokine coreceptor signaling in HIV-1 infection and pathogenesis. PLoS Pathog. 2009, 5:e1000520.
52. Wu Y., Zhou B.P. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br. J. Cancer 2010, 102:639-644.
53. Wynn R.F., Hart C.A., Corradi-Perini C., O'Neill L., Evans C.A., Wraith J.E., Fairbairn L.J., Bellantuono I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004, 104:2643-2645.
54. Ye R.D. Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J. Leukoc. Biol. 2001, 70:839-848.
55. Yona S., Jung S. Monocytes: subsets, origins, fates and functions. Curr. Opin. Hematol. 2010, 17:53-59.
56. Yun D.H., Song H.Y., Lee M.J., Kim M.R., Kim M.Y., Lee J.S., Kim J.H. Thromboxane A(2) modulates migration, proliferation, and differentiation of adipose tissue-derived mesenchymal stem cells. Exp. Mol. Med. 2009, 41:17-24.